Figure 1 | Scientific Reports

Figure 1

From: Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases

Figure 1The alternative text for this image may have been generated using AI.

Stool: microbiome diversity based on 16S rRNA gene sequencing in stool in the control and inflammatory bowel disease (IBD) groups before (V1) and after (V2) anti-TNF-α treatment. (A) α-Diversity analysis of gut microbiota using ACE, Chao 1, Shannon, and Simpson index. (B) β-Diversity analysis of gut microbiota calculated via Principal coordinate analysis (PCoA) scatter plot. Differences between the relative abundance of microbiota were calculated by the Kruskal–Wallis test and Wilcoxon test.

Back to article page